Enhancing immune responses of ESC-based TAA cancer vaccines with a novel OMV delivery system
Meiling Jin(Shenzhen University Health Science Center), Jian‐Dong Huang(Sun Yat-sen University), Shuzhen Liu(Qingdao University), Da Huo(Cornell University), Bao‐Zhong Zhang(Daqing Oilfield General Hospital), Jingchu Hu(BGI Group (China)), Mingshuo Zhan(Chinese Academy of Sciences), Jingjing Sun(Singapore-MIT Alliance for Research and Technology)
Cited by 24
Related Papers
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
|Clinical Infectious Diseases|2020|818
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
|Molecular Cancer|2011|700
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Genomic instability in laminopathy-based premature aging
|Nature Medicine|2005|641